SCHEMBL3980972

SCHEMBL3980972

CCOC(=O)c1occ(-c2cccc(OCc3c(C)c(C)cc(C)c3C)c2)c1-c1cccc(OCc2c(C)c(C)cc(C)c2C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.40
FABP3 P05413 1/20 0.38
FABP4 P15090 1/20 0.38
FABP5 Q01469 1/20 0.38
CD274 Q9NZQ7 2/20 0.38
PDCD1 Q15116 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
PPARG P37231 1/20 0.37
BRD4 O60885 1/20 0.37
BRD2 P25440 1/20 0.37
CREBBP Q92793 1/20 0.37
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
HPGD P15428 1/20 0.36
PTGS2 P35354 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGER4 P35408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3982728 0.96 MAPT (0.41) FFAR1FABP3FABP4FABP5CD274
SCHEMBL3973638 0.96 FABP3 (0.43) FFAR1FABP3FABP4FABP5CD274
SCHEMBL3978466 0.86 PPARG (0.51) FFAR1PPARGJAK2JAK3MAPT
SCHEMBL3983858 0.85 FFAR1 (0.42) FFAR1FABP3FABP4FABP5CD274
SCHEMBL27605311 0.85 PTGER4 (0.44) FFAR1FABP3FABP4FABP5CD274
SCHEMBL28752668 0.85 PTGER4 (0.44) FFAR1FABP3FABP4FABP5CD274
SCHEMBL3982581 0.84 PPARG (0.51) FFAR1CD274PPARGJAK2JAK3
SCHEMBL3982596 0.84 PPARG (0.51) FFAR1FABP3FABP4FABP5PPARG
SCHEMBL3979268 0.82 FFAR1 (0.43) FFAR1CD274PTGER4
SCHEMBL3979293 0.82 FABP3 (0.41) FFAR1FABP3FABP4FABP5CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 FFAR1 7/4885FABP3 1207/4885FABP4 1815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.